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Abstract. Background: Insulin Resistance (IR) causes a metabolic disorder including 
hyperglycemia, high blood pressure, and dyslipidemia. The purpose of the study was to assess 
the relationship of Triglycerides and Glucose Index (Tyg) decline relationship with lipid 
profile after bay leaf extract treatment in dyslipidemia patients. Method: Fifteen dyslipidemia 
patients were administered 2x200 mg salam leaf extract capsules for 30 days. Criteria 
dyslipidemia is defined as one of the following: total cholesterol level ≥ 240 mg/dL, 
triglyceride levels ≥150 mg/dL, LDL cholesterol levels ≥140 mg/dL, HDL cholesterol levels 
<40 mg/dL, or the use of lipid-lowering drugs. Blood samples lipid profile for biochemical 
tests were drawn in the morning after fasting 12 h. Anthropometric BMI and waist 
circumference measures were taken using standard procedures. The TG/HDL-C ratio was 
calculated by dividing the serum concentration of TG by HDL-C measured in mg/dL. TyG 
index was calculated based on formula: Ln [TG (mg/dL) x FG (mg/dL). Result: After 30 days 
of salam leaf extract treatment, there was a significant correlation of TyG reduction with 
parameters TC, LDL-C, TG, TG/HD ratio (p: 0.025*, p: 0.001*, p: 0.013*, sequentially) 
Conclusion: There is a significant correlation between Tyg reduction with TC, TG, and 
TG/HDL, which leads to a decrease in cardiovascular risk in dyslipidemia patients. 
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Abstrak. Latar belakang: Resistensi insulin (RI) menyebabkan gangguan metabolisme 
termasuk hiperglikemia, tekanan darah tinggi, dan dislipidemia. Tujuan penelitian adalah 
menilai hubungan penurunan index TyG dengan profil lipid setelah pengobatan ekstrak daun 
salam pada pasien dislipidemia. Metode: Lima belas pasien dislipidemia diberikan 2x200 
mg kapsul ekstrak daun salam selama 30 hari.Dan Kriteria dislipidemia didefinisikan 
sebagai salah satu dari yang berikut: tingkat kolesterol total ≥ 240 mg/dL, kadar trigliserida 
≥150 mg/dL, kadar kolesterol LDL  ≥140 mg/dL, kadar kolesterol HDL <40 mg/dL, atau 
penggunaan obat penurun lipid. Sampel darah profil lipid untuk uji biokimia diambil pada 
pagi hari setelah puasa 12 jam. Pengukuran IMT antropometri dan lingkar pinggang 
menggunakan prosedur standar. Rasio TG / HDL-C dihitung dengan membagi konsentrasi 
serum TG dengan HDL-C diukur dalam mg / dL. Indeks TyG dihitung berdasarkan rumus: 
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Ln [TG (mg / dL) x FG (mg / dL). Hasil: Setelah pengobatan ekstrak daun salam selama 30 
hari, terdapat korelasi signifikan penurunan TyG dengan parameter TC, LDL-C, TG, rasio 
TG/HD (p: 0.025*, p: 0.001*, p: 0.013*, secara berurutan). Kesimpulan: Terdapat korelasi 
yang signifikan antara penurunan TyG dengan TC, TG dan TG/HDL, yang menujukan 
penurunan risiko kardiovaskular pada pasien dislipidemia 
Kata Kunci: TyG, Dislipdemia, Syzygium Polyanthum (Wight) Walp 
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1 Introduction 
Insulin resistance (IR) causes decreased cell sensitivity to insulin and is a central characteristic of 
metabolic syndrome (MS). IR tends to cause metabolic disorders including hyperglycemia, high 
blood pressure, and dyslipidemia all associated with diabetes, atherosclerosis, and cardiovascular 
disease. IR evaluation requires advanced methods and is not available in daily clinical practice. 
[2] Hyperinsulinemic-euglycemic clamp is a direct method of measuring IR and is considered a 
gold standard procedure, but difficult to perform in daily practice. Instead of IR examination 
includes the assessment of homeostatic IR (HOMA-IR) models i.e. measurement of fasting 
glucose and insulin levels. [3] Due to the difficulty of assessing the RI, sought other practical 
ways.[4] Other alternatives assess IR by measuring plasma TG and HDL cholesterol (TG/HDL-
C),[5] and TG/plasma/glucose called triglyceride and glucose index (TyG).[6] TyG is associated 
with HOMA-IR, insulin suppression tests, and hyperinsulinemic-euglycemic clamps. [7]  
Bay leaves contain tannin, galokatekin, flavonoids, saponins (triterpenoid), and essential oils 
(sesquiterpenes). Bay leaves also contain several vitamins, including vitamin A, vitamin C, 
vitamin E, thiamine, riboflavin, niacin, vitamin B6, vitamin B12, and folate. The results of in vitro 
studies showed that flavonoids work as inhibitors of the HMG-CoA reductase enzyme so that 
cholesterol synthesis decreases. An estimated 75 - 80% of people in developing countries and 
25% in developed countries use traditional medicine as first-line treatment. The administration of 
bay leaf extract 400 mg per day for 30 days there was a significant decrease in TC, LDL, TG (p: 
0.012, p: 0.035, p: 0.009, sequentially) in dyslipidemia patients.[8]. 
The purpose of the study was to assess the relationship of TyG index decline as a sign of RI with 
lipid profile after treatment of bay leaf extract in dyslipidemia patients  
2 Method 
Fifteen dyslipidemia patients were given 2x200 mg of bay leaf extract capsules for 30 days. 
Subject dyslipidemia with other inflammations, infections, use of anti-inflammatory drugs, and 
secondary dyslipidemia excluded from the study. Dyslipidemia criteria are defined as one of the 
following: total cholesterol levels ≥ 240 mg/dL, triglyceride levels ≥150 mg/dL, low-density 
lipoprotein (LDL) cholesterol levels ≥140 mg/dL, high-density lipoprotein (HDL) cholesterol 
levels <40 mg/dL, or the use of lipid-lowering drugs. Blood samples lipid profile for biochemical 
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tests were drawn in the morning, after fasting 12 h. Anthropometric measures were taken using 
standard procedures. [9] Waist circumference (cm) was measured halfway between the lower 
lateral margin of the last rib and the anterior superior region of the iliac crest while standing, using 
a flexible, not distensible measuring tape. Body mass index was calculated as weight (kg)/height 
(m)2. The TyG index was calculated as the natural logarithm (Ln) of the product of plasma 
glucose and TG using the formula: Ln (TG [mg/dL] Å~ glucose [mg/dL]/2).[6] The TG/HDL-C 
ratio was calculated by dividing the serum concentration of TG by HDL-C measured in mg/dL. 
TyG index was calculated based on formula: Ln [TG (mg/dL) x FG (mg/dL)/2], according to the 
previous studies. [10] 
All statistical analyses were performed using the SPSS statistical package for Windows (version 
16.0, SPSS). Kolmogorov–Smirnov test was used to test the normality of the distribution of 
variables. The differences within groups were analyzed by the dependent t-test where appropriate. 
Univariate correlation coefficients were determined by Spearman analysis. 
3 Result 
In table 1, all study patients were male, dyslipidemia and overwight/obese. 
Table 1 Basic data of research subjects 
Variable  
Age (years) 50.40 + 5.22 
WC (cm) 88,33 + 7,18 
BMI (kg/m2) 27.54 + 3.22 
FBS (mg/dL) 94,20 + 15,03 
TC (mg/dL) 229,13 + 14,99 
LDL-C (mg/dL) 155,00 + 22,55 
HDL-C (mg/dL) 51,13 + 7,73 
TG (mg/dL 149,93 + 70,56 
TG/HDL 3.10 + 1.84 
TyG 4.80+0.41 
Note: WC: waist circumference; BMI: body mass index; FBS: fasting blood sugar; TC: total 
cholesterol; LDL-C: low density lipoprotein; HDL-C: high density lipoprotein; TG: triglyceride: TyG: 
Triglycerides And Glucose Index 
In table 2, there were significant differences in TC, LDL-C, TG, TG/HDL ratios, while TyG 
decreased but not significantly. 
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Table 2 Differences in TyG and lipid profile after treatment 
Variabel D0 
Mean ± SD 
D30 
Mean ± SD 
pa 
WC (cm) 91.46 ± 4.43 91.50 ± 4.37 0.109 
BMI (kg/m2) 27.54 ± 3.21 27.53 ± 3.19 1.000 
FBS (mg/dL) 94.20 ± 15.03 89.06 ± 13.24 0.116 
TC (mg/dL) 229,13 + 14,99 217,53 + 23,10 0,012* 
LDL-C (mg/dL) 155,00 + 22,55 145,67 + 29,37 0,035* 
HDL-C (mg/dL) 51,13 + 7,73 50,07 + 7,5 0,318 
TG (mg/dL 149,93 + 70,56 112,13 + 37,92 0,009* 
TG/HDL 3.1 + 1.84 2.40 + 0.98 0.040* 
TyG 4.80 + 0.41 4.66 + 0.48 0.317 
                     Note: WC: waist circumference; BMI: body mass index; FBS: fasting blood sugar; TC: total                       
                     cholesterol; LDL-C: low density lipoprotein; HDL-C: high density lipoprotein; TG:  
                      triglyceride: TyG: Triglycerides and Glucose Index. 
In table 3. There is a significant correlation between TyG and TC, TG and TG/HDL 
Table 3 Correlation between TyG and lipid profiles after treatment  
Variabel r p 
WC (cm) 0.297 0.283 
BMI (kg/m2) 0.246 0.377 
FBS (mg/dL) 0.164 0.559 
TC (mg/dL) 0.573 0.025* 
LDL-C (mg/dL) 0.475 0.074 
HDL-C (mg/dL) -0.278 0.315 
TG (mg/dL) 0.786 0.001* 
TG/HDL 0.625 0.013* 
                              Note: WC: waist circumference; BMI: body mass index;  
                              TC: total cholesterol; LDL-C: low density lipoprotein; HDL-C: high density  
                              lipoprotein; TG:triglyceride:  
4 Discussion 
Average Indeks TyG and TG/HDL-C ratio are very high in subjects with MS compared to those 
without MS. TyG index also increases as the number of MS components increases, and there is a 
good correlation between TyG index and TG/HDL-C ratio. This data is consistent with previous 
evidence that supports TyG index values and TG/HDL-C ratios as IR markers.[6] TyG can help 
to assess IR as it shows sensitivity (96.5%) and specificity (85.0%) when assessed compared to 
hyperinsulinemic-euglycemic clamp.[11] 
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The studies conducted in the non-diabetic population, that the TyG index and TC/HDL-C ratio 
have a moderate correlation just like the index that uses fasting insulin, assessing glucose 
absorption by insulin, then this indicates that alternative IR markers based on lipid measurements 
help detect IR. Due to the similarity of the cut-off index points of TyG to distinguish in men (8.8) 
and women (8.7) MS in research, sex stratification is considered unnecessary use in daily clinical 
practice. 
However, more studies are needed to validate this index in other populations to generalize the 
cut-off value. TG/HDL-C ratio value, in the overall MS population, is 2.4, in contrast to TyG 
index which is different after sex stratification. The cut-off points reported in the study were 2.2 
for women and 3.1 for men, similar to the values reported by Salazar et al in Argentina's 
population (2.5 for women and 3.5 for men).[12] The TG/HDL cholesterol ratio was positively 
associated with the prevalence of silent brain infarct (SBI) in a neurologically healthy population,[ 
13] and an independent predictor of all-cause mortality and cardiovascular events,[14] The TyG 
index was significantly associated with the risk of incident diabetes and could be a valuable 
biomarker of developing diabetes,[15] a predictor of incident CKD,[16] and predictor of impaired 
glucose tolerance in overweight and obese adolescents.[17] 
In this study, TyG was significantly correlated with TC, TG, and TG/HDL, leading to 
cardiovascular risk in dyslipidemia patients. 
5 Conclusions  
There is a significant correlation between tyg reduction with TC, TG and TG/HDL, this leads to 
cardiovascular risk in dyslipidemia patients. 
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